Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regen BioPharma (RGBP) Interest & Investment Income (2016 - 2018)

Historic Interest & Investment Income for Regen BioPharma (RGBP) over the last 5 years, with Q4 2018 value amounting to $1302.0.

  • Regen BioPharma's Interest & Investment Income fell 7700.87% to $1302.0 in Q4 2018 from the same period last year, while for Sep 2019 it was $1302.0, marking a year-over-year decrease of 9154.44%. This contributed to the annual value of $455.0 for FY2022, which is N/A changed from last year.
  • Regen BioPharma's Interest & Investment Income amounted to $1302.0 in Q4 2018, which was down 7700.87% from $113.0 recorded in Q3 2018.
  • Regen BioPharma's 5-year Interest & Investment Income high stood at $5741.0 for Q2 2018, and its period low was $14.0 during Q2 2014.
  • Its 5-year average for Interest & Investment Income is $1112.4, with a median of $300.0 in 2015.
  • Examining YoY changes over the last 5 years, Regen BioPharma's Interest & Investment Income showed a top increase of 1425250.0% in 2018 and a maximum decrease of 9077.55% in 2018.
  • Quarter analysis of 5 years shows Regen BioPharma's Interest & Investment Income stood at $260.0 in 2014, then rose by 15.38% to $300.0 in 2015, then changed by 0.0% to $300.0 in 2016, then surged by 1787.67% to $5663.0 in 2017, then crashed by 77.01% to $1302.0 in 2018.
  • Its Interest & Investment Income was $1302.0 in Q4 2018, compared to $113.0 in Q3 2018 and $5741.0 in Q2 2018.